A tetrameric peptide derived from bovine lactoferricin as a potential therapeutic tool for oral squamous cell carcinoma: A preclinical model

Files

A tetrameric peptide derived from bovine lactoferricin as a potential therapeutic tool for oral squamous cell carcinoma A preclinical model____COMPLETO.pdf (2.42 MB)

Date

2017

Type:

Artículo

Collections

Artículos Medicina y Ciencias de la Salud

Descargas totales

28

Vistas totales

2
Gestores bibliográficos

Authors

item.contributor.advisor

ORCID:

Journal Title

Journal ISSN

Volume Title

Publisher

PLoS

item.page.isbn

item.page.issn

item.page.issne

item.page.doiurl

URI

http://hdl.handle.net/11447/1623
 http://dx.doi.org/10.1371/journal.pone.0174707

item.page.extent

17

item.page.accessRights

item.page.other

item.page.references

Abstract

Oral squamous cell carcinoma is the fifth most common epithelial cancer in the world, and its current clinical treatment has both low efficiency and poor selectivity. Cationic amphipathic peptides hav...

Description

item.page.coverage.spatial

item.page.sponsorship

Citation

Solarte VA, Conget P, Vernot JP, Rosas JE, Rivera ZJ, García JE, Arango-Rodríguez ML. A tetrameric peptide derived from bovine lactoferricin as a potential therapeutic tool for oral squamous cell carcinoma: A preclinical model. PLoS One. 2017 Mar 30;12(3):e0174707.

Keywords

cancer treatment , hamsters , apoptosis , histology , white blood cells , cell membranes , inflammation , necrosis

item.page.dc.rights

item.page.dc.rights.url

Estadísticas de uso
2 1,5 1 0,5 0
Agosto 2025Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026

Implementado por OpenGeek Services